nanostring technologies (nasdaq: nstg) is a publicly held provider of life science tools for translational research and molecular diagnostics. the company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. nanostring technologies provides life science tools for translational research and molecular diagnostic products. the company's ncounter® analysis system, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 300 peer-reviewed publications, has also now been applied to diagnostic use as the ncounter dx analysis system. the company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, mirnas, or copy number variations, simultaneously with high sensitivity and precision. the company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and vali
Company profile
Ticker
NSTG
Exchange
Website
CEO
R. Bradley Gray
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
NanoString Technologies Europe Limited • NanoString Technologies SAS • NanoString Technologies International, Inc. • NanoString Technologies Germany GmbH • NanoString Technologies Asia Pacific Limited • NanoString Technologies Singapore Pte Limited • NanoString Technologies (Beijing) Co. Ltd. • NanoString Technologies Spain, S.L. • NanoString Technologies Netherlands B.V. ...
IRS number
200094687
NSTG stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
22 Apr 24
8-K
NanoString Technologies to Be Acquired by Bruker Corporation
19 Apr 24
25-NSE
Exchange delisting
9 Apr 24
8-K
Regulation FD Disclosure
22 Mar 24
NT 10-K
Notice of late annual filing
15 Mar 24
8-K
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
11 Mar 24
8-K
Bankruptcy or Receivership
13 Feb 24
8-K
Entry into a Material Definitive Agreement
8 Feb 24
8-K
Nanostring Takes Steps to Restructure Its Business and Protect Its Mission to
5 Feb 24
8-K
Departure of Directors or Certain Officers
25 Jan 24
Transcripts
NSTG
Earnings call transcript
2023 Q3
6 Nov 23
NSTG
Earnings call transcript
2023 Q2
3 Aug 23
NSTG
Earnings call transcript
2023 Q1
3 May 23
NSTG
Earnings call transcript
2022 Q4
28 Feb 23
NSTG
Earnings call transcript
2022 Q3
7 Nov 22
NSTG
Earnings call transcript
2022 Q2
7 Aug 22
NSTG
Earnings call transcript
2022 Q1
11 May 22
NSTG
Earnings call transcript
2021 Q4
2 Mar 22
NSTG
Earnings call transcript
2021 Q3
10 Nov 21
NSTG
Earnings call transcript
2021 Q2
5 Aug 21
Latest ownership filings
4
Teresa M. Foy
19 Apr 24
4
JANET GEORGE
11 Mar 24
4
DANA E. ROLLISON
11 Mar 24
4
JOSEPH M BEECHEM
7 Mar 24
4
K Thomas Bailey
7 Mar 24
4
R BRADLEY GRAY
7 Mar 24
SC 13G/A
BlackRock Inc.
7 Mar 24
SC 13G/A
PURA VIDA INVESTMENTS, LLC
14 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G
BARCLAYS PLC
14 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 94.10 mm | 94.10 mm | 94.10 mm | 94.10 mm | 94.10 mm | 94.10 mm |
Cash burn (monthly) | 6.94 mm | 1.91 mm | 12.49 mm | 13.85 mm | 6.57 mm | 9.58 mm |
Cash used (since last report) | 47.95 mm | 13.22 mm | 86.22 mm | 95.64 mm | 45.34 mm | 66.16 mm |
Cash remaining | 46.15 mm | 80.88 mm | 7.87 mm | -1.54 mm | 48.76 mm | 27.94 mm |
Runway (months of cash) | 6.6 | 42.3 | 0.6 | -0.1 | 7.4 | 2.9 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 119 |
Opened positions | 16 |
Closed positions | 42 |
Increased positions | 48 |
Reduced positions | 35 |
13F shares | Current |
---|---|
Total value | 83.63 bn |
Total shares | 56.29 mm |
Total puts | 348.20 k |
Total calls | 142.50 k |
Total put/call ratio | 2.4 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 4.63 mm | $7.97 bn |
Clarus Lifesciences II | 4.12 mm | $50.33 mm |
Polar Capital | 3.98 mm | $6.84 bn |
Blue Water Life Science Advisors | 3.75 mm | $6.45 bn |
Vanguard | 3.57 mm | $6.14 bn |
Prosight Management | 3.45 mm | $5.93 bn |
Titanite Investment Management | 2.80 mm | $7.90 mm |
Avidity Partners Management | 2.30 mm | $3.95 bn |
Platinum Investment Management | 2.29 mm | $3.93 bn |
D. E. Shaw & Co. | 2.12 mm | $3.65 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Apr 24 | Teresa M. Foy | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,841 | 0.00 | 10,116 |
18 Apr 24 | Teresa M. Foy | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,841 | 0.00 | 3,842 |
8 Mar 24 | Janet George | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,676 | 0.00 | 20,944 |
8 Mar 24 | Janet George | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,676 | 0.00 | 0 |
8 Mar 24 | Dana E. Rollison | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,676 | 0.00 | 20,944 |
8 Mar 24 | Dana E. Rollison | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,676 | 0.00 | 0 |
5 Mar 24 | Joseph M Beechem | Common Stock | Option exercise | Acquire M | No | No | 0 | 34,848 | 0.00 | 141,090 |
5 Mar 24 | Joseph M Beechem | Common Stock | Option exercise | Acquire M | No | No | 0 | 8,460 | 0.00 | 106,242 |
5 Mar 24 | Joseph M Beechem | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,765 | 0.00 | 97,782 |
5 Mar 24 | Joseph M Beechem | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 34,848 | 0.00 | 69,697 |
News
12 Health Care Stocks Moving In Tuesday's After-Market Session
13 Feb 24
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
13 Feb 24
12 Health Care Stocks Moving In Tuesday's Intraday Session
13 Feb 24
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
12 Feb 24
12 Health Care Stocks Moving In Monday's Intraday Session
12 Feb 24
Press releases
Thinking about buying stock in Confluent, Dell Technologies, CleanSpark, NanoString Technologies, or Affirm?
9 Feb 24
NanoString Announces Completion of Financing to Support Restructuring Process
9 Feb 24
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
4 Feb 24
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
1 Feb 24